Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of Cell Source, Inc. from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Cell Source, Inc. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2022 to Q3 2024.
  • Cell Source, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2024 was $23K, a 790% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Cell Source, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $23K +$20.4K +790% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $90.5K +$68.6K +312% 30 Jun 2024 10-Q 19 Aug 2024
Q4 2023 $22.2K -$200K -90% 31 Dec 2023 10-Q 14 Nov 2024
Q3 2023 $2.58K 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $22K 30 Jun 2023 10-Q 19 Aug 2024
Q4 2022 $223K 31 Dec 2022 10-Q 14 Nov 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.